| pubmed-article:11540050 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11540050 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:11540050 | lifeskim:mentions | umls-concept:C0031603 | lld:lifeskim |
| pubmed-article:11540050 | lifeskim:mentions | umls-concept:C0028953 | lld:lifeskim |
| pubmed-article:11540050 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11540050 | lifeskim:mentions | umls-concept:C1522492 | lld:lifeskim |
| pubmed-article:11540050 | lifeskim:mentions | umls-concept:C0205679 | lld:lifeskim |
| pubmed-article:11540050 | lifeskim:mentions | umls-concept:C0133819 | lld:lifeskim |
| pubmed-article:11540050 | pubmed:issue | 24 | lld:pubmed |
| pubmed-article:11540050 | pubmed:dateCreated | 1997-10-18 | lld:pubmed |
| pubmed-article:11540050 | pubmed:abstractText | The effects of amine structure on the montmorillonite-catalyzed oligomerization of the 5'-phosphoramidates of adenosine are investigated. 4-Aminopyridine derivatives yielded oligoadenylates as long as dodecamers with a regioselectivity for 3',5'-phosphodiester bond formation averaging 88%. Linear and cyclic oligomers are obtained and no A5'ppA-containing products are detected. Oligomers as long as the hexanucleotide are obtained using 2-aminobenzimidazole as the activating group. A predominance of pA2'pA is detected in the dimer fraction along with cyclic 3',5'-trimer; no A5'ppA-containing oligomers were detected. Little or no oligomer formation was observed when morpholine, piperidine, pyrazole, 1,2,4-triazole, and 2-pyridone are used as phosphate-activating groups. The effects of the structure of the phosphate activating group on the oligomer structure and chain lengths are discussed. | lld:pubmed |
| pubmed-article:11540050 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11540050 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:citationSubset | S | lld:pubmed |
| pubmed-article:11540050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11540050 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11540050 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11540050 | pubmed:issn | 0002-7863 | lld:pubmed |
| pubmed-article:11540050 | pubmed:author | pubmed-author:FerrisJ PJP | lld:pubmed |
| pubmed-article:11540050 | pubmed:author | pubmed-author:PrabaharK JKJ | lld:pubmed |
| pubmed-article:11540050 | pubmed:author | pubmed-author:ColeT DTD | lld:pubmed |
| pubmed-article:11540050 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11540050 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:11540050 | pubmed:volume | 116 | lld:pubmed |
| pubmed-article:11540050 | pubmed:owner | NASA | lld:pubmed |
| pubmed-article:11540050 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11540050 | pubmed:pagination | 10914-20 | lld:pubmed |
| pubmed-article:11540050 | pubmed:dateRevised | 2007-8-1 | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:meshHeading | pubmed-meshheading:11540050... | lld:pubmed |
| pubmed-article:11540050 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:11540050 | pubmed:articleTitle | Effect of phosphate activating group on oligonucleotide formation on montmorillonite: the regioselective formation of 3',5'-linked oligoadenylates. | lld:pubmed |
| pubmed-article:11540050 | pubmed:affiliation | Department of Chemistry, Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA. | lld:pubmed |
| pubmed-article:11540050 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11540050 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11540050 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:11540050 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11540050 | lld:pubmed |
